Modafinil (Provigil) & Blood Pressure: Monitoring & Management

Modafinil (Provigil) is a wake-promoting agent for narcolepsy, OSA, shift work disorder. Blood pressure elevation is a known but uncommon side effect.

Evidence on BP Effects

  • Clinical trials: Mean SBP/DBP increase 1–3 mmHg vs. placebo; clinically significant hypertension (≥140/90 new onset or worsening) in ~2–5%.
  • Mechanism: Norepinephrine/dopamine reuptake inhibition → sympathetic tone ↑; possible direct vascular effects.
  • Dose-related: Higher doses (300–400 mg) > 200 mg.
  • Time course: Peaks 2–4 hrs post-dose; sustained with chronic use.

Monitoring Recommendations

  • Baseline BP before starting.
  • Monthly x 3 months, then every 3–6 months if stable.
  • Home BP log (morning/evening) for patients with prehypertension/hypertension.

Management If BP Rises

  1. Confirm with repeat measurements (proper technique).
  2. Lifestyle: sodium <2.3 g, DASH diet, exercise, weight loss, limit alcohol.
  3. If persistent >140/90: consider dose reduction (200 → 100 mg) or switch agent (armodafinil, solriamfetol, pitolisant).
  4. Add antihypertensive if indicated (ACEi/ARB, CCB, thiazide).
  5. Do not stop abruptly if benefiting—taper not required but discuss with prescriber.
  6. Special Populations

    • Cardiovascular disease: Use caution; monitor closely; consider alternatives.
    • Elderly: More sensitive to pressor effects.
    • Combination with stimulants: Additive BP/HR effects—avoid if possible.

    Most patients tolerate modafinil well. Vigilant monitoring ensures early intervention.

Hypertension - Related Articles